Annekathryn Goodman
Overview
Explore the profile of Annekathryn Goodman including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
111
Citations
1243
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Russo A, Depauw N, Horick N, Wo J, Nyamwanda J, Giap F, et al.
Int J Radiat Oncol Biol Phys
. 2025 Mar;
PMID: 40089072
Purpose/objective(s): Patients with node-positive (LN+) uterine or cervical cancer often require post-operative radiation (RT) to the pelvis and para-aortic nodes. A prospective phase II study was conducted to evaluate the...
2.
Subramanian S, Tseng B, Del Carmen M, Goodman A, Dahl D, Barbieri R, et al.
Proc Natl Acad Sci U S A
. 2024 Sep;
121(40):e2319316121.
PMID: 39316050
Monitoring nociception, the flow of information associated with harmful stimuli through the nervous system even during unconsciousness, is critical for proper anesthesia care during surgery. Currently, this is done by...
3.
Barakzai S, Bregar A, Carmen M, Eisenhauer E, Goodman A, Rauh-Hain J, et al.
Gynecol Oncol
. 2024 Aug;
190:119-123.
PMID: 39178527
Objective: We conducted a multi-institutional observational study to investigate whether maintenance hormone therapy following primary treatment of low-grade advanced-stage ovarian cancer (LGSOC) is associated with an overall survival advantage. Methods:...
4.
5.
Silberman J, Bercow A, Gockley A, Eisenhauer E, Sisodia R, Randall T, et al.
Gynecol Oncol
. 2023 Jun;
175:60-65.
PMID: 37327540
Objective: To describe trends in neoadjuvant chemotherapy (NACT) use for low-grade serous ovarian carcinoma (LGSOC) and to quantify associations between NACT and extent of cytoreductive surgery. Methods: We identified women...
6.
7.
Kanbergs A, Sullivan M, Maner M, Brinkley-Rubinstein L, Goodman A, Davis M, et al.
Am J Prev Med
. 2023 Jan;
64(2):244-249.
PMID: 36653100
Introduction: The objective of this study is to better understand cervical cancer screening and follow-up practices in U.S. prisons. Methods: A 29-question survey examining cervical cancer screening practices, education, and...
8.
Philp L, Alimena S, Sullivan M, Del Carmen M, Bregar A, Eisenhauer E, et al.
Int J Gynecol Cancer
. 2023 Jan;
33(5):770-777.
PMID: 36639193
Objective: Race remains a significant predictor of poor outcomes in women with gynecologic cancer and minority patients consistently report worse quality of life during cancer treatment. Disparities between patients in...
9.
Bercow A, Rauh-Hain J, Melamed A, Mazina V, Growdon W, Carmen M, et al.
Gynecol Oncol
. 2022 Dec;
169:47-54.
PMID: 36508758
Objective: To evaluate utilization of sentinel lymph node biopsy (SLNB) for early-stage vulvar cancer at minority-serving hospitals and low-volume facilities. Methods: Between 2012-2018, individuals with T1b vulvar squamous cell carcinoma...
10.
Bercow A, Rauh-Hain J, Melamed A, Mazina V, Growdon W, Carmen M, et al.
Obstet Gynecol
. 2022 Nov;
140(6):1031-1041.
PMID: 36357957
Objective: To describe the use of National Comprehensive Cancer Network guideline-concordant inguinofemoral lymph node (LN) evaluation in individuals with early-stage vulvar cancer. Methods: This retrospective cohort study identified patients with...